Stay updated on Early Alirocumab to Reduce LDL-C in Myocardial Infarction Clinical Trial
Sign up to get notified when there's something new on the Early Alirocumab to Reduce LDL-C in Myocardial Infarction Clinical Trial page.

Latest updates to the Early Alirocumab to Reduce LDL-C in Myocardial Infarction Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedA new revision entry (v3.3.3) was added to the Record History, and the footer removed the HHS Vulnerability Disclosure and the earlier Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page history now shows a new revision entry: Revision: v3.3.2. This is a minor metadata update related to the revision history.SummaryDifference0.1%

- Check38 days agoChange DetectedRevision v3.3.1 was added to the Study Record Versions, and Revision v3.2.0 was deleted.SummaryDifference0.1%

- Check46 days agoChange DetectedDeleted a general operating-status notice about government funding; it does not alter the study record or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check60 days agoChange DetectedVersion 2 (2019-06-11) updates the study record with a Recruitment Status change. This reflects a new enrollment status for the EARLY trial (NCT03750760).SummaryDifference0.1%

- Check88 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference13%

Stay in the know with updates to Early Alirocumab to Reduce LDL-C in Myocardial Infarction Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Early Alirocumab to Reduce LDL-C in Myocardial Infarction Clinical Trial page.